Healthy Life Agritec Posts FY26 Growth Amidst Auditor Concerns

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorAarav Shah|Published at:
Healthy Life Agritec Posts FY26 Growth Amidst Auditor Concerns

Healthy Life Agritec reported increased revenue and profit for FY26, but auditors flagged significant compliance failures and documentation issues, raising concerns for investors.

Healthy Life Agritec: FY26 Growth Mixed with Auditor Concerns

Healthy Life Agritec Ltd. reported standalone revenue of ₹107.07 crore and net profit of ₹2.46 crore for the fiscal year ended March 31, 2026. Consolidated figures showed revenue at ₹228.14 crore and net profit at ₹4.00 crore.

Reader Takeaway: Revenue grew, but audit flags compliance and verification issues.

What just happened

Healthy Life Agritec Limited has announced its financial results for the fiscal year 2025-26. The company saw a rise in both standalone and consolidated revenues and profits. Additionally, the company raised ₹24.81 crore through a rights issue during the fiscal year, reporting no deviation in fund utilization.

Why this matters

While the financial growth is positive, the company's Independent Auditor's Report for FY26 raises several critical concerns. These include irregularities in TDS compliance, failure to comply with EPF and ESI provisions, unavailability of internal audit reports, outstanding income tax liabilities, and delays in GST filings. Auditors also noted that key balance sheet items were certified by management rather than independently verified.

The backstory

The company operates in the agri-tech sector. While specific historical financial data is not detailed in this filing, the current report covers FY25 and FY26 performance and audit observations for the latter.

What changes now

Investors need to closely assess the implications of the auditor's observations. The identified compliance failures and lack of independent verification for significant financial items could lead to potential future liabilities and impact investor confidence. The company's ability to address these audit remarks will be crucial.

Risks to watch

Key risks include penalties for non-compliance with TDS, EPF, and ESI regulations, potential issues arising from unverified financial statements, and the impact on future audits. Delays in tax filings and outstanding liabilities also pose a risk.

Peer comparison

(No peer comparison data is available in the provided filing.)

Context metrics (time-bound)

  • Standalone Revenue: ₹107.07 crore (FY26) vs ₹64.45 crore (FY25)
  • Standalone Net Profit: ₹2.46 crore (FY26) vs ₹1.87 crore (FY25)
  • Consolidated Revenue: ₹228.14 crore (FY26) vs ₹171.87 crore (FY25)
  • Consolidated Net Profit: ₹4.00 crore (FY26) vs ₹3.26 crore (FY25)
  • Rights Issue Funds Raised: ₹24.81 crore (FY26)

What to track next

Investors should monitor future filings for the company's actions to rectify compliance issues, improve internal audit reporting, and ensure independent verification of financial statements. Any further disclosures regarding tax liabilities or regulatory actions will be important to track.

Disclaimer:This article is published for informational purposes only. While reasonable efforts are made to ensure accuracy, completeness, and timeliness, readers are encouraged to independently verify information before making any decisions based on the content. The views and information presented are subject to editorial review and may be updated without notice.